Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?

Authors:
Bryant C; Mendenhall NP; Henderson RH; Nichols RC; Mendenhall WM and 5 more

Journal:
Am J Clin Oncol

Publication Year: 2016

DOI:
10.1097/COC.0000000000000050

PMCID:
PMC4876577

PMID:
24710124

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Am J Clin Oncol

Abbreviation: Am J Clin Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Characteristics Associated With Survival in Surgically Nonresected Pancreatic Adenocarcinoma in the…
Eaglehouse YL; Darmon S; Gage MM and 2 more (2023) - Transparency Score: 3/6
Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After H…
Ding Q; Wang K; Li Y and 7 more (2023) - Transparency Score: 2/6
Management Strategies and Outcomes in Primary Liver Angiosarcoma.
Ramakrishnan N; Mokhtari R; Charville GW and 2 more (2023) - Transparency Score: 2/6
Prognostic Value of the Cutoffs for HALP in Endometrial Cancer.
Wang J; Jiang P; Huang Y and 5 more (2023) - Transparency Score: 2/6
Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance i…
Chan JK; Liu J; Song J and 5 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"B.S.H. received an honorarium from Procure for a lecture on proton therapy techniques for lung cancer. The other authors declare no conflicts of interest."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025